YAP1 is also a non-redundant oncogenic driver in MLPS (interacting with the translocation FUS-DDIT3 in the nucleus) [36,65] and a promoter of ERMS development through the transformation of satellite cells [36,66]. This evidence concerns the gene YAP1 and embryonal rhabdomyosarcoma.